Filing Details

Accession Number:
0001477449-24-000043
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 16:09:12
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 16:09:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1477449 Teladoc Health Inc. TDOC Services-Offices & Clinics Of Doctors Of Medicine (8011) 043705970
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
2001935 P. Nikolaos Nanis C/O Teladoc Health, Inc.,
2 Manhattanville Road, Suite 203
Purchase NY 10577
Chief Technology Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-03-01 1,479 $0.00 66,510 No 4 M Direct
Common Stock Acquisiton 2024-03-01 505 $0.00 67,015 No 4 M Direct
Common Stock Acquisiton 2024-03-01 894 $0.00 67,909 No 4 M Direct
Common Stock Acquisiton 2024-03-01 4,340 $0.00 72,249 No 4 M Direct
Common Stock Acquisiton 2024-03-01 467 $0.00 72,716 No 4 M Direct
Common Stock Disposition 2024-03-04 2,866 $14.52 69,850 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Stock Units Acquisiton 2024-03-01 4,437 $0.00 4,437 $0.00
Common Stock Performance Stock Units Disposition 2024-03-01 1,479 $0.00 1,479 $0.00
Common Stock Restricted Stock Units Disposition 2024-03-01 505 $0.00 505 $0.00
Common Stock Restricted Stock Units Disposition 2024-03-01 894 $0.00 894 $0.00
Common Stock Restricted Stock Units Disposition 2024-03-01 4,340 $0.00 4,340 $0.00
Common Stock Restricted Stock Units Disposition 2024-03-01 467 $0.00 467 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,437 No 4 A Direct
2,958 No 4 M Direct
2,023 No 4 M Direct
4,472 No 4 M Direct
8,681 No 4 M Direct
0 No 4 M Direct
Footnotes
  1. Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
  2. Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  3. Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's performance stock unit and restricted stock unit awards.
  4. Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
  5. Performance award amount determined based on metrics in respect of the issuer's 2023 financial results.
  6. The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  7. On March 1, 2024, the reporting person earned 4,437 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  8. On March 1, 2022, the reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  9. On June 1, 2022, the reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  10. On March 3, 2023, the reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
  11. On March 2, 2021, the reporting person was granted 1,400 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.